Your research, seen by everyone.

The research network for physicians and researchers. Every specialty, one app.

Not published much? The same cards keep you current on your whole field in minutes a day.

Free forever. Choose email or Google on the next page.

Cohort Study · Internal Medicine

Low serum albumin independently predicted massive pulmonary embolism in this cohort.

AOR = 13.615

low albumin sharply raises the odds of massive, high-risk pulmonary embolism

Cureus · 2026

Cohort Study · Internal Medicine

Amount of thrombus removed did not correlate with pulmonary artery pressure improvement.

ρ = 0.10

clot amount removed didn't predict pressure improvement

Clinical research in cardiology · 2026

Cohort Study · Internal Medicine

Statin use associated with lower odds of venous thromboembolism in high-risk trauma patients

OR 0.209

statin users had far lower odds of developing a blood clot

The journal of trauma and acute care surgery · 2026

Every number comes straight from the abstract, and every card links back to the paper. Sourced from PubMed · NEJM · JAMA · The Lancet · Cochrane.

01Stay current

Never behind on your field again.

New papers in your specialties show up as cards the week they publish. A few minutes a day and you are caught up.

In your specialties

Cross-sectional · Internal MedicineThrombosis research

Relatives' venous thromboembolism risk nearly 10-fold higher when index case had early, multiple-relative venous thromboembolism

SIR 9.93

Limited evidence

Cohort Study · Internal MedicinePediatric blood & cancer

Obese adolescents using combined oral contraceptives had double the pulmonary embolism risk

RR = 2.33

Moderate evidence

Cohort Study · Internal MedicineThrombosis research

Isolated lupus anticoagulant positivity linked to higher venous thromboembolism rates in antiphospholipid syndrome

67%

Moderate evidence

Cohort Study · Internal MedicineEinstein (Sao Paulo, Brazil)

Only 34.4% of primary antiphospholipid syndrome patients had adequate anticoagulation control

34.4%

Moderate evidence

02Where the field talks

Your whole field, talking in one place.

Say what you think about a new finding. Talk it through with the people who ran the study and the ones putting it into practice. Follow the colleagues and topics you care about, and it all lands in one feed.

→ A comment thread under every paper
→ Follow people and specialties, or message colleagues directly
→ Verified profiles, so you know who you are talking to

Cohort Study · Internal MedicineLife (Basel, Switzerland) · 2026

Reperfusion therapy independently associated with lower 90-day mortality in high-risk pulmonary embolism

OR 0.05reperfusion cut 90-day death risk by about 95%

Dr. James Okafor· Neurology

The 24-hour window changes how we triage overnight admissions. Curious how centers are staffing for it.

Dr. Sana Patel· Emergency Medicine

We moved to a 24/7 on-call interventional roster last quarter. Happy to share the protocol.

♥ 48💬 12 repliesJoin the discussion

Your work belongs in front of your field.

Free for everyone. No credit card, no catch.